What 3D sensing “total solution” opportunity? Oppenheimer’s Andrew Uerkwitz is not taking the gamble on HIMX shares.
Though the rest of the Street is celebrating Under Armour’s quarterly print today, FBR’s Susan Anderson isn’t budging from the bearish camp.
General Electric Company (NYSE:GE) is like that driver motoring down the highway with the ever-blinking turn signal. Those following along behind are left …
BTIG’s Tim Chiang is out with a bearish case against Teva after last week’s less-than-stellar 2018 guidance reveal.
Pivotal’s Brian Wieser sees no reason to substantially change his long-term model, leaving him bearish on Snap’s bigger picture- for now.
Generics price erosion; the ghost of debt maturation- BTIG’s Tim Chiang sees too many risks to hope for Teva’s recovery anymore.
Twitter Inc (NYSE:TWTR) is doing the right thing by cutting costs, turning its business into a sustainable enterprise instead of a bottomless money …
As MannKind spends precious cash, it moves closer to the next capital raise (a.k.
RBC Capital’s Randall Stanicky says everything rides on Teva’s power to keep a grip on 2020 revenue.
Goldman Sachs’ Dana Flanders sheds new insights on Valeant from a bearish standpoint, spotting 5% in loss potential for the stock.